124 related articles for article (PubMed ID: 32703405)
1. Novel N-cadherin antagonist causes glioblastoma cell death in a 3D bioprinted co-culture model.
Smits IPM; Blaschuk OW; Willerth SM
Biochem Biophys Res Commun; 2020 Aug; 529(2):162-168. PubMed ID: 32703405
[TBL] [Abstract][Full Text] [Related]
2. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
Civita P; M Leite D; Pilkington GJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
[TBL] [Abstract][Full Text] [Related]
3. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.
Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ
FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660
[TBL] [Abstract][Full Text] [Related]
4. Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier.
Tang M; Rich JN; Chen S
Adv Mater; 2021 Feb; 33(5):e2004776. PubMed ID: 33326131
[TBL] [Abstract][Full Text] [Related]
5. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
6. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
7. A 3D bioprinted hydrogel mesh loaded with all-trans retinoic acid for treatment of glioblastoma.
Mirani B; Pagan E; Shojaei S; Duchscherer J; Toyota BD; Ghavami S; Akbari M
Eur J Pharmacol; 2019 Jul; 854():201-212. PubMed ID: 30974104
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
9. OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.
Berenguer-Daizé C; Astorgues-Xerri L; Odore E; Cayol M; Cvitkovic E; Noel K; Bekradda M; MacKenzie S; Rezai K; Lokiec F; Riveiro ME; Ouafik L
Int J Cancer; 2016 Nov; 139(9):2047-55. PubMed ID: 27388964
[TBL] [Abstract][Full Text] [Related]
10. Three dimensional in vitro models of cancer: Bioprinting multilineage glioblastoma models.
Hermida MA; Kumar JD; Schwarz D; Laverty KG; Di Bartolo A; Ardron M; Bogomolnijs M; Clavreul A; Brennan PM; Wiegand UK; Melchels FP; Shu W; Leslie NR
Adv Biol Regul; 2020 Jan; 75():100658. PubMed ID: 31727590
[TBL] [Abstract][Full Text] [Related]
11. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics.
Heinrich MA; Bansal R; Lammers T; Zhang YS; Michel Schiffelers R; Prakash J
Adv Mater; 2019 Apr; 31(14):e1806590. PubMed ID: 30702785
[TBL] [Abstract][Full Text] [Related]
12. High-resolution tomographic analysis of in vitro 3D glioblastoma tumor model under long-term drug treatment.
Ozturk MS; Lee VK; Zou H; Friedel RH; Intes X; Dai G
Sci Adv; 2020 Mar; 6(10):eaay7513. PubMed ID: 32181351
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening.
Wang L; Zhao H; Cui K; Yao L; Ren M; Hao A; Smollen P; Nie F; Jin G; Liu Q; Wong ST
Biosci Trends; 2012 Aug; 6(4):192-200. PubMed ID: 23006966
[TBL] [Abstract][Full Text] [Related]
14. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study.
Schiariti MP; Restelli F; Ferroli P; Benetti A; Berenzi A; Ferri A; Ceserani V; Ciusani E; Cadei M; Finocchiaro G; Pessina A; Parati E; Pallini R; Alessandri G
Cytotherapy; 2017 Jun; 19(6):721-734. PubMed ID: 28434806
[TBL] [Abstract][Full Text] [Related]
16. A rapid assay for drug sensitivity of glioblastoma stem cells.
Gal H; Makovitzki A; Amariglio N; Rechavi G; Ram Z; Givol D
Biochem Biophys Res Commun; 2007 Jul; 358(3):908-13. PubMed ID: 17512905
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
18. Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme.
Bona NP; Pedra NS; Azambuja JH; Soares MSP; Spohr L; Gelsleichter NE; de M Meine B; Sekine FG; Mendonça LT; de Oliveira FH; Braganhol E; Spanevello RM; da Silveira EF; Stefanello FM
Metab Brain Dis; 2020 Feb; 35(2):283-293. PubMed ID: 31773434
[TBL] [Abstract][Full Text] [Related]
19. Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.
Grinshtein N; Rioseco CC; Marcellus R; Uehling D; Aman A; Lun X; Muto O; Podmore L; Lever J; Shen Y; Blough MD; Cairncross GJ; Robbins SM; Jones SJ; Marra MA; Al-Awar R; Senger DL; Kaplan DR
Oncotarget; 2016 Sep; 7(37):59360-59376. PubMed ID: 27449082
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.
Areeb Z; Stylli SS; Ware TM; Harris NC; Shukla L; Shayan R; Paradiso L; Li B; Morokoff AP; Kaye AH; Luwor RB
Med Oncol; 2016 May; 33(5):53. PubMed ID: 27098175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
